Meridian Bioscience: Q2 Earnings Insights

Meridian Bioscience NASDAQ:VIVO reported its Q2 earnings results on Friday, May 6, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Meridian Bioscience beat estimated earnings by 40.43%, reporting an EPS of $0.66 versus an estimate of $0.47.

Revenue was up $25.97 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 12.16% increase in the share price the next day.

Here's a look at Meridian Bioscience's past performance:

To track all earnings releases for Meridian Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.